nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A4—breast cancer	0.0984	1	CbGaD
Triazolam—CYP2C9—Anastrozole—breast cancer	0.0309	0.0545	CbGbCtD
Triazolam—CYP3A5—Lapatinib—breast cancer	0.0308	0.0542	CbGbCtD
Triazolam—CYP2C8—Lapatinib—breast cancer	0.0296	0.0521	CbGbCtD
Triazolam—CYP3A4—Exemestane—breast cancer	0.0237	0.0418	CbGbCtD
Triazolam—CYP2C9—Idarubicin—breast cancer	0.0234	0.0413	CbGbCtD
Triazolam—CYP2C8—Raloxifene—breast cancer	0.0224	0.0395	CbGbCtD
Triazolam—CYP3A7—Tamoxifen—breast cancer	0.0205	0.0362	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0205	0.0362	CbGbCtD
Triazolam—CYP3A4—Letrozole—breast cancer	0.0202	0.0356	CbGbCtD
Triazolam—CYP3A4—Anastrozole—breast cancer	0.018	0.0317	CbGbCtD
Triazolam—CYP3A4—Toremifene—breast cancer	0.0164	0.029	CbGbCtD
Triazolam—CYP3A7—Paclitaxel—breast cancer	0.016	0.0282	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.016	0.0282	CbGbCtD
Triazolam—CYP3A7—Irinotecan—breast cancer	0.0158	0.0278	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0158	0.0278	CbGbCtD
Triazolam—CYP3A5—Tamoxifen—breast cancer	0.0154	0.0271	CbGbCtD
Triazolam—CYP3A4—Fulvestrant—breast cancer	0.0153	0.0269	CbGbCtD
Triazolam—CYP2C8—Tamoxifen—breast cancer	0.0148	0.0261	CbGbCtD
Triazolam—CYP3A4—Thiotepa—breast cancer	0.0136	0.024	CbGbCtD
Triazolam—CYP2C9—Capecitabine—breast cancer	0.0128	0.0226	CbGbCtD
Triazolam—CYP3A4—Ixabepilone—breast cancer	0.0125	0.022	CbGbCtD
Triazolam—CYP3A4—Lapatinib—breast cancer	0.012	0.0211	CbGbCtD
Triazolam—CYP3A5—Paclitaxel—breast cancer	0.012	0.0211	CbGbCtD
Triazolam—CYP3A5—Irinotecan—breast cancer	0.0118	0.0208	CbGbCtD
Triazolam—CYP3A7—Docetaxel—breast cancer	0.0116	0.0204	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0116	0.0204	CbGbCtD
Triazolam—CYP2C8—Paclitaxel—breast cancer	0.0115	0.0203	CbGbCtD
Triazolam—CYP2C8—Fluorouracil—breast cancer	0.0109	0.0192	CbGbCtD
Triazolam—CYP2C9—Tamoxifen—breast cancer	0.0103	0.0182	CbGbCtD
Triazolam—CYP3A4—Raloxifene—breast cancer	0.00909	0.016	CbGbCtD
Triazolam—CYP3A5—Docetaxel—breast cancer	0.00867	0.0153	CbGbCtD
Triazolam—CYP2C9—Paclitaxel—breast cancer	0.00804	0.0142	CbGbCtD
Triazolam—CYP2C9—Fluorouracil—breast cancer	0.00761	0.0134	CbGbCtD
Triazolam—CYP3A4—Vinorelbine—breast cancer	0.00665	0.0117	CbGbCtD
Triazolam—CYP3A4—Tamoxifen—breast cancer	0.00601	0.0106	CbGbCtD
Triazolam—CYP3A4—Mitoxantrone—breast cancer	0.00586	0.0103	CbGbCtD
Triazolam—CYP3A4—Paclitaxel—breast cancer	0.00467	0.00824	CbGbCtD
Triazolam—CYP3A4—Irinotecan—breast cancer	0.00461	0.00813	CbGbCtD
Triazolam—CYP3A4—Vinblastine—breast cancer	0.0041	0.00723	CbGbCtD
Triazolam—CYP3A4—Docetaxel—breast cancer	0.00338	0.00596	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—breast cancer	0.00252	0.00444	CbGbCtD
Triazolam—GABRP—mammary gland—breast cancer	0.00146	0.0511	CbGeAlD
Triazolam—GABRP—nipple—breast cancer	0.0012	0.0422	CbGeAlD
Triazolam—GABRE—mammary gland—breast cancer	0.00111	0.039	CbGeAlD
Triazolam—GABRG3—pituitary gland—breast cancer	0.00095	0.0333	CbGeAlD
Triazolam—GABRE—nipple—breast cancer	0.000919	0.0323	CbGeAlD
Triazolam—TSPO—nipple—breast cancer	0.000858	0.0301	CbGeAlD
Triazolam—GABRB1—pituitary gland—breast cancer	0.000734	0.0258	CbGeAlD
Triazolam—GABRP—endometrium—breast cancer	0.000727	0.0255	CbGeAlD
Triazolam—CYP2C8—mammary gland—breast cancer	0.000712	0.025	CbGeAlD
Triazolam—TSPO—embryo—breast cancer	0.000708	0.0248	CbGeAlD
Triazolam—GABRP—uterus—breast cancer	0.00067	0.0235	CbGeAlD
Triazolam—GABRA4—pituitary gland—breast cancer	0.000663	0.0233	CbGeAlD
Triazolam—GABRP—pituitary gland—breast cancer	0.000658	0.0231	CbGeAlD
Triazolam—CYP3A7—endocrine gland—breast cancer	0.000639	0.0224	CbGeAlD
Triazolam—CYP2C9—mammary gland—breast cancer	0.000632	0.0222	CbGeAlD
Triazolam—Clonazepam—NAT2—breast cancer	0.000611	0.238	CrCbGaD
Triazolam—GABRP—female reproductive system—breast cancer	0.000602	0.0211	CbGeAlD
Triazolam—TSPO—epithelium—breast cancer	0.000578	0.0203	CbGeAlD
Triazolam—GABRE—endometrium—breast cancer	0.000555	0.0195	CbGeAlD
Triazolam—GABRG2—pituitary gland—breast cancer	0.000554	0.0194	CbGeAlD
Triazolam—TSPO—skin of body—breast cancer	0.00055	0.0193	CbGeAlD
Triazolam—GABRA3—endocrine gland—breast cancer	0.000527	0.0185	CbGeAlD
Triazolam—TSPO—endometrium—breast cancer	0.000518	0.0182	CbGeAlD
Triazolam—GABRA2—adipose tissue—breast cancer	0.000504	0.0177	CbGeAlD
Triazolam—GABRR2—lymph node—breast cancer	0.000504	0.0177	CbGeAlD
Triazolam—GABRE—pituitary gland—breast cancer	0.000502	0.0176	CbGeAlD
Triazolam—GABRE—adipose tissue—breast cancer	0.0005	0.0175	CbGeAlD
Triazolam—TSPO—uterus—breast cancer	0.000477	0.0168	CbGeAlD
Triazolam—TSPO—pituitary gland—breast cancer	0.000469	0.0165	CbGeAlD
Triazolam—TSPO—adipose tissue—breast cancer	0.000467	0.0164	CbGeAlD
Triazolam—GABRE—female reproductive system—breast cancer	0.00046	0.0161	CbGeAlD
Triazolam—GABRA2—adrenal gland—breast cancer	0.000452	0.0159	CbGeAlD
Triazolam—GABRE—adrenal gland—breast cancer	0.000449	0.0157	CbGeAlD
Triazolam—TSPO—female reproductive system—breast cancer	0.000429	0.0151	CbGeAlD
Triazolam—GABRB3—pituitary gland—breast cancer	0.000426	0.0149	CbGeAlD
Triazolam—TSPO—adrenal gland—breast cancer	0.000419	0.0147	CbGeAlD
Triazolam—GABRE—female gonad—breast cancer	0.000418	0.0147	CbGeAlD
Triazolam—TSPO—bone marrow—breast cancer	0.000405	0.0142	CbGeAlD
Triazolam—TSPO—female gonad—breast cancer	0.000391	0.0137	CbGeAlD
Triazolam—GABRB3—female reproductive system—breast cancer	0.00039	0.0137	CbGeAlD
Triazolam—TSPO—endocrine gland—breast cancer	0.000363	0.0127	CbGeAlD
Triazolam—CYP2C8—endometrium—breast cancer	0.000356	0.0125	CbGeAlD
Triazolam—GABRB3—endocrine gland—breast cancer	0.00033	0.0116	CbGeAlD
Triazolam—CYP2C8—pituitary gland—breast cancer	0.000322	0.0113	CbGeAlD
Triazolam—CYP2C8—female reproductive system—breast cancer	0.000295	0.0103	CbGeAlD
Triazolam—CYP3A5—adipose tissue—breast cancer	0.000289	0.0101	CbGeAlD
Triazolam—GABRA2—lymph node—breast cancer	0.000271	0.00952	CbGeAlD
Triazolam—GABRE—lymph node—breast cancer	0.000269	0.00944	CbGeAlD
Triazolam—CYP2C9—female reproductive system—breast cancer	0.000262	0.00918	CbGeAlD
Triazolam—TSPO—lymph node—breast cancer	0.000251	0.00881	CbGeAlD
Triazolam—CYP2C8—endocrine gland—breast cancer	0.000249	0.00874	CbGeAlD
Triazolam—CYP3A5—female gonad—breast cancer	0.000242	0.00849	CbGeAlD
Triazolam—CYP3A5—endocrine gland—breast cancer	0.000225	0.00789	CbGeAlD
Triazolam—CYP2C9—endocrine gland—breast cancer	0.000221	0.00777	CbGeAlD
Triazolam—CYP3A4—female reproductive system—breast cancer	0.0002	0.007	CbGeAlD
Triazolam—CYP3A4—endocrine gland—breast cancer	0.000169	0.00592	CbGeAlD
Triazolam—Chlordiazepoxide—CYP2D6—breast cancer	0.000134	0.052	CrCbGaD
Triazolam—Stomatitis—Methotrexate—breast cancer	0.000119	0.000546	CcSEcCtD
Triazolam—Ill-defined disorder—Capecitabine—breast cancer	0.000119	0.000546	CcSEcCtD
Triazolam—Headache—Vinorelbine—breast cancer	0.000118	0.000545	CcSEcCtD
Triazolam—Syncope—Docetaxel—breast cancer	0.000118	0.000545	CcSEcCtD
Triazolam—Palpitations—Docetaxel—breast cancer	0.000117	0.000537	CcSEcCtD
Triazolam—Loss of consciousness—Docetaxel—breast cancer	0.000116	0.000534	CcSEcCtD
Triazolam—Malaise—Capecitabine—breast cancer	0.000115	0.00053	CcSEcCtD
Triazolam—Insomnia—Paclitaxel—breast cancer	0.000115	0.000529	CcSEcCtD
Triazolam—Hypersensitivity—Irinotecan—breast cancer	0.000115	0.000528	CcSEcCtD
Triazolam—Hypersensitivity—Mitoxantrone—breast cancer	0.000115	0.000528	CcSEcCtD
Triazolam—Vomiting—Thiotepa—breast cancer	0.000115	0.000528	CcSEcCtD
Triazolam—Syncope—Capecitabine—breast cancer	0.000115	0.000527	CcSEcCtD
Triazolam—Chlordiazepoxide—CYP3A4—breast cancer	0.000115	0.0446	CrCbGaD
Triazolam—Paraesthesia—Paclitaxel—breast cancer	0.000114	0.000525	CcSEcCtD
Triazolam—Hypertension—Docetaxel—breast cancer	0.000114	0.000524	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—breast cancer	0.000114	0.000524	CcSEcCtD
Triazolam—Dermatitis—Thiotepa—breast cancer	0.000114	0.000523	CcSEcCtD
Triazolam—Dyspnoea—Paclitaxel—breast cancer	0.000113	0.000521	CcSEcCtD
Triazolam—Headache—Thiotepa—breast cancer	0.000113	0.00052	CcSEcCtD
Triazolam—Somnolence—Paclitaxel—breast cancer	0.000113	0.00052	CcSEcCtD
Triazolam—Palpitations—Capecitabine—breast cancer	0.000113	0.00052	CcSEcCtD
Triazolam—Chest pain—Docetaxel—breast cancer	0.000112	0.000517	CcSEcCtD
Triazolam—Loss of consciousness—Capecitabine—breast cancer	0.000112	0.000517	CcSEcCtD
Triazolam—Nausea—Vinorelbine—breast cancer	0.000112	0.000516	CcSEcCtD
Triazolam—Asthenia—Irinotecan—breast cancer	0.000112	0.000514	CcSEcCtD
Triazolam—Asthenia—Mitoxantrone—breast cancer	0.000112	0.000514	CcSEcCtD
Triazolam—Jaundice—Epirubicin—breast cancer	0.000111	0.000511	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—breast cancer	0.000111	0.000511	CcSEcCtD
Triazolam—Clonazepam—CYP3A4—breast cancer	0.000111	0.0431	CrCbGaD
Triazolam—Dysuria—Doxorubicin—breast cancer	0.000111	0.000509	CcSEcCtD
Triazolam—Decreased appetite—Paclitaxel—breast cancer	0.00011	0.000508	CcSEcCtD
Triazolam—Hypertension—Capecitabine—breast cancer	0.00011	0.000508	CcSEcCtD
Triazolam—Hypersensitivity—Fluorouracil—breast cancer	0.00011	0.000506	CcSEcCtD
Triazolam—Dry mouth—Docetaxel—breast cancer	0.00011	0.000506	CcSEcCtD
Triazolam—Fatigue—Paclitaxel—breast cancer	0.00011	0.000504	CcSEcCtD
Triazolam—Asthenia—Gemcitabine—breast cancer	0.000109	0.000501	CcSEcCtD
Triazolam—Chest pain—Capecitabine—breast cancer	0.000109	0.000501	CcSEcCtD
Triazolam—Constipation—Paclitaxel—breast cancer	0.000109	0.0005	CcSEcCtD
Triazolam—Pain—Paclitaxel—breast cancer	0.000109	0.0005	CcSEcCtD
Triazolam—Confusional state—Docetaxel—breast cancer	0.000109	0.0005	CcSEcCtD
Triazolam—Anxiety—Capecitabine—breast cancer	0.000108	0.000499	CcSEcCtD
Triazolam—Oedema—Docetaxel—breast cancer	0.000108	0.000496	CcSEcCtD
Triazolam—Discomfort—Capecitabine—breast cancer	0.000107	0.000495	CcSEcCtD
Triazolam—Pruritus—Gemcitabine—breast cancer	0.000107	0.000494	CcSEcCtD
Triazolam—Nausea—Thiotepa—breast cancer	0.000107	0.000493	CcSEcCtD
Triazolam—Diarrhoea—Irinotecan—breast cancer	0.000107	0.000491	CcSEcCtD
Triazolam—Diarrhoea—Mitoxantrone—breast cancer	0.000107	0.000491	CcSEcCtD
Triazolam—Dry mouth—Capecitabine—breast cancer	0.000106	0.00049	CcSEcCtD
Triazolam—Shock—Docetaxel—breast cancer	0.000106	0.000488	CcSEcCtD
Triazolam—Pruritus—Fluorouracil—breast cancer	0.000106	0.000486	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—breast cancer	0.000105	0.000485	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—breast cancer	0.000105	0.000485	CcSEcCtD
Triazolam—Confusional state—Capecitabine—breast cancer	0.000105	0.000484	CcSEcCtD
Triazolam—Tachycardia—Docetaxel—breast cancer	0.000105	0.000484	CcSEcCtD
Triazolam—Feeling abnormal—Paclitaxel—breast cancer	0.000105	0.000482	CcSEcCtD
Triazolam—Oedema—Capecitabine—breast cancer	0.000104	0.00048	CcSEcCtD
Triazolam—Gastrointestinal pain—Paclitaxel—breast cancer	0.000104	0.000478	CcSEcCtD
Triazolam—Diarrhoea—Gemcitabine—breast cancer	0.000104	0.000478	CcSEcCtD
Triazolam—Dizziness—Irinotecan—breast cancer	0.000103	0.000474	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—breast cancer	0.000103	0.000473	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—breast cancer	0.000103	0.000473	CcSEcCtD
Triazolam—Clotiazepam—CYP3A4—breast cancer	0.000103	0.04	CrCbGaD
Triazolam—Anorexia—Docetaxel—breast cancer	0.000103	0.000472	CcSEcCtD
Triazolam—Shock—Capecitabine—breast cancer	0.000103	0.000472	CcSEcCtD
Triazolam—Diarrhoea—Fluorouracil—breast cancer	0.000102	0.00047	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—breast cancer	0.000102	0.000469	CcSEcCtD
Triazolam—Tachycardia—Capecitabine—breast cancer	0.000102	0.000468	CcSEcCtD
Triazolam—Hyperhidrosis—Capecitabine—breast cancer	0.000101	0.000464	CcSEcCtD
Triazolam—Abdominal pain—Paclitaxel—breast cancer	0.0001	0.000462	CcSEcCtD
Triazolam—Anorexia—Capecitabine—breast cancer	9.94e-05	0.000457	CcSEcCtD
Triazolam—Vomiting—Irinotecan—breast cancer	9.91e-05	0.000456	CcSEcCtD
Triazolam—Vomiting—Mitoxantrone—breast cancer	9.91e-05	0.000456	CcSEcCtD
Triazolam—Dizziness—Fluorouracil—breast cancer	9.87e-05	0.000454	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—breast cancer	9.85e-05	0.000453	CcSEcCtD
Triazolam—Dermatitis—Mitoxantrone—breast cancer	9.81e-05	0.000452	CcSEcCtD
Triazolam—Dermatitis—Irinotecan—breast cancer	9.81e-05	0.000452	CcSEcCtD
Triazolam—Headache—Irinotecan—breast cancer	9.76e-05	0.000449	CcSEcCtD
Triazolam—Headache—Mitoxantrone—breast cancer	9.76e-05	0.000449	CcSEcCtD
Triazolam—Insomnia—Docetaxel—breast cancer	9.74e-05	0.000448	CcSEcCtD
Triazolam—Alprazolam—CYP3A4—breast cancer	9.7e-05	0.0378	CrCbGaD
Triazolam—Clobazam—CYP3A4—breast cancer	9.7e-05	0.0378	CrCbGaD
Triazolam—Diazepam—PTGS1—breast cancer	9.7e-05	0.0378	CrCbGaD
Triazolam—Paraesthesia—Docetaxel—breast cancer	9.67e-05	0.000445	CcSEcCtD
Triazolam—Vomiting—Gemcitabine—breast cancer	9.65e-05	0.000444	CcSEcCtD
Triazolam—Clonazepam—ALB—breast cancer	9.65e-05	0.0376	CrCbGaD
Triazolam—Dyspnoea—Docetaxel—breast cancer	9.6e-05	0.000442	CcSEcCtD
Triazolam—Somnolence—Docetaxel—breast cancer	9.57e-05	0.000441	CcSEcCtD
Triazolam—Dermatitis—Gemcitabine—breast cancer	9.56e-05	0.00044	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—breast cancer	9.53e-05	0.000439	CcSEcCtD
Triazolam—Erythema—Methotrexate—breast cancer	9.51e-05	0.000438	CcSEcCtD
Triazolam—Headache—Gemcitabine—breast cancer	9.51e-05	0.000438	CcSEcCtD
Triazolam—Vomiting—Fluorouracil—breast cancer	9.49e-05	0.000437	CcSEcCtD
Triazolam—Insomnia—Capecitabine—breast cancer	9.43e-05	0.000434	CcSEcCtD
Triazolam—Quazepam—CYP3A4—breast cancer	9.4e-05	0.0366	CrCbGaD
Triazolam—Dermatitis—Fluorouracil—breast cancer	9.4e-05	0.000433	CcSEcCtD
Triazolam—Paraesthesia—Capecitabine—breast cancer	9.36e-05	0.000431	CcSEcCtD
Triazolam—Decreased appetite—Docetaxel—breast cancer	9.36e-05	0.000431	CcSEcCtD
Triazolam—Hypersensitivity—Paclitaxel—breast cancer	9.36e-05	0.000431	CcSEcCtD
Triazolam—Headache—Fluorouracil—breast cancer	9.35e-05	0.00043	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—breast cancer	9.31e-05	0.000429	CcSEcCtD
Triazolam—Dyspnoea—Capecitabine—breast cancer	9.3e-05	0.000428	CcSEcCtD
Triazolam—Fatigue—Docetaxel—breast cancer	9.29e-05	0.000427	CcSEcCtD
Triazolam—Nausea—Mitoxantrone—breast cancer	9.25e-05	0.000426	CcSEcCtD
Triazolam—Nausea—Irinotecan—breast cancer	9.25e-05	0.000426	CcSEcCtD
Triazolam—Pain—Docetaxel—breast cancer	9.21e-05	0.000424	CcSEcCtD
Triazolam—Constipation—Docetaxel—breast cancer	9.21e-05	0.000424	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—breast cancer	9.12e-05	0.00042	CcSEcCtD
Triazolam—Asthenia—Paclitaxel—breast cancer	9.12e-05	0.00042	CcSEcCtD
Triazolam—Decreased appetite—Capecitabine—breast cancer	9.06e-05	0.000417	CcSEcCtD
Triazolam—Nausea—Gemcitabine—breast cancer	9.01e-05	0.000415	CcSEcCtD
Triazolam—Fatigue—Capecitabine—breast cancer	8.99e-05	0.000414	CcSEcCtD
Triazolam—Pruritus—Paclitaxel—breast cancer	8.99e-05	0.000414	CcSEcCtD
Triazolam—Constipation—Capecitabine—breast cancer	8.92e-05	0.00041	CcSEcCtD
Triazolam—Pain—Capecitabine—breast cancer	8.92e-05	0.00041	CcSEcCtD
Triazolam—Erythema—Epirubicin—breast cancer	8.9e-05	0.00041	CcSEcCtD
Triazolam—Flunitrazepam—CYP3A4—breast cancer	8.88e-05	0.0346	CrCbGaD
Triazolam—Feeling abnormal—Docetaxel—breast cancer	8.88e-05	0.000408	CcSEcCtD
Triazolam—Nausea—Fluorouracil—breast cancer	8.86e-05	0.000408	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—breast cancer	8.83e-05	0.000406	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—breast cancer	8.82e-05	0.000406	CcSEcCtD
Triazolam—Gastrointestinal pain—Docetaxel—breast cancer	8.81e-05	0.000405	CcSEcCtD
Triazolam—Flatulence—Epirubicin—breast cancer	8.77e-05	0.000404	CcSEcCtD
Triazolam—Tension—Epirubicin—breast cancer	8.73e-05	0.000402	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—breast cancer	8.72e-05	0.000401	CcSEcCtD
Triazolam—Diarrhoea—Paclitaxel—breast cancer	8.69e-05	0.0004	CcSEcCtD
Triazolam—Nervousness—Epirubicin—breast cancer	8.65e-05	0.000398	CcSEcCtD
Triazolam—Feeling abnormal—Capecitabine—breast cancer	8.59e-05	0.000395	CcSEcCtD
Triazolam—Malaise—Methotrexate—breast cancer	8.58e-05	0.000395	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—breast cancer	8.56e-05	0.000394	CcSEcCtD
Triazolam—Gastrointestinal pain—Capecitabine—breast cancer	8.53e-05	0.000392	CcSEcCtD
Triazolam—Abdominal pain—Docetaxel—breast cancer	8.51e-05	0.000392	CcSEcCtD
Triazolam—Dizziness—Paclitaxel—breast cancer	8.4e-05	0.000387	CcSEcCtD
Triazolam—Estazolam—CYP3A4—breast cancer	8.31e-05	0.0324	CrCbGaD
Triazolam—Ill-defined disorder—Epirubicin—breast cancer	8.26e-05	0.00038	CcSEcCtD
Triazolam—Abdominal pain—Capecitabine—breast cancer	8.24e-05	0.000379	CcSEcCtD
Triazolam—Erythema—Doxorubicin—breast cancer	8.24e-05	0.000379	CcSEcCtD
Triazolam—Agitation—Epirubicin—breast cancer	8.18e-05	0.000376	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—breast cancer	8.12e-05	0.000373	CcSEcCtD
Triazolam—Chest pain—Methotrexate—breast cancer	8.1e-05	0.000373	CcSEcCtD
Triazolam—Tension—Doxorubicin—breast cancer	8.08e-05	0.000372	CcSEcCtD
Triazolam—Vomiting—Paclitaxel—breast cancer	8.08e-05	0.000372	CcSEcCtD
Triazolam—Clobazam—ABCB1—breast cancer	8.07e-05	0.0314	CrCbGaD
Triazolam—Dysgeusia—Doxorubicin—breast cancer	8.07e-05	0.000371	CcSEcCtD
Triazolam—Malaise—Epirubicin—breast cancer	8.03e-05	0.000369	CcSEcCtD
Triazolam—Dermatitis—Paclitaxel—breast cancer	8e-05	0.000368	CcSEcCtD
Triazolam—Discomfort—Methotrexate—breast cancer	8e-05	0.000368	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—breast cancer	8e-05	0.000368	CcSEcCtD
Triazolam—Syncope—Epirubicin—breast cancer	7.98e-05	0.000367	CcSEcCtD
Triazolam—Headache—Paclitaxel—breast cancer	7.96e-05	0.000366	CcSEcCtD
Triazolam—Hypersensitivity—Docetaxel—breast cancer	7.94e-05	0.000365	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—breast cancer	7.92e-05	0.000364	CcSEcCtD
Triazolam—Adinazolam—CYP3A4—breast cancer	7.91e-05	0.0308	CrCbGaD
Triazolam—Palpitations—Epirubicin—breast cancer	7.87e-05	0.000362	CcSEcCtD
Triazolam—Confusional state—Methotrexate—breast cancer	7.83e-05	0.00036	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—breast cancer	7.82e-05	0.00036	CcSEcCtD
Triazolam—Asthenia—Docetaxel—breast cancer	7.73e-05	0.000356	CcSEcCtD
Triazolam—Hypertension—Epirubicin—breast cancer	7.68e-05	0.000354	CcSEcCtD
Triazolam—Hypersensitivity—Capecitabine—breast cancer	7.68e-05	0.000354	CcSEcCtD
Triazolam—Prazepam—CYP3A4—breast cancer	7.64e-05	0.0298	CrCbGaD
Triazolam—Ill-defined disorder—Doxorubicin—breast cancer	7.64e-05	0.000352	CcSEcCtD
Triazolam—Pruritus—Docetaxel—breast cancer	7.62e-05	0.000351	CcSEcCtD
Triazolam—Chest pain—Epirubicin—breast cancer	7.58e-05	0.000349	CcSEcCtD
Triazolam—Agitation—Doxorubicin—breast cancer	7.57e-05	0.000348	CcSEcCtD
Triazolam—Anxiety—Epirubicin—breast cancer	7.55e-05	0.000348	CcSEcCtD
Triazolam—Nausea—Paclitaxel—breast cancer	7.55e-05	0.000347	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—breast cancer	7.5e-05	0.000345	CcSEcCtD
Triazolam—Discomfort—Epirubicin—breast cancer	7.49e-05	0.000345	CcSEcCtD
Triazolam—Asthenia—Capecitabine—breast cancer	7.48e-05	0.000344	CcSEcCtD
Triazolam—Malaise—Doxorubicin—breast cancer	7.43e-05	0.000342	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—breast cancer	7.41e-05	0.000341	CcSEcCtD
Triazolam—Anorexia—Methotrexate—breast cancer	7.4e-05	0.000341	CcSEcCtD
Triazolam—Syncope—Doxorubicin—breast cancer	7.39e-05	0.00034	CcSEcCtD
Triazolam—Pruritus—Capecitabine—breast cancer	7.38e-05	0.00034	CcSEcCtD
Triazolam—Diarrhoea—Docetaxel—breast cancer	7.37e-05	0.000339	CcSEcCtD
Triazolam—Confusional state—Epirubicin—breast cancer	7.32e-05	0.000337	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—breast cancer	7.28e-05	0.000335	CcSEcCtD
Triazolam—Oedema—Epirubicin—breast cancer	7.26e-05	0.000334	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—breast cancer	7.24e-05	0.000333	CcSEcCtD
Triazolam—Shock—Epirubicin—breast cancer	7.15e-05	0.000329	CcSEcCtD
Triazolam—Diarrhoea—Capecitabine—breast cancer	7.13e-05	0.000328	CcSEcCtD
Triazolam—Flurazepam—CYP3A4—breast cancer	7.13e-05	0.0278	CrCbGaD
Triazolam—Dizziness—Docetaxel—breast cancer	7.12e-05	0.000328	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—breast cancer	7.11e-05	0.000327	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—breast cancer	7.09e-05	0.000326	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—breast cancer	7.02e-05	0.000323	CcSEcCtD
Triazolam—Insomnia—Methotrexate—breast cancer	7.02e-05	0.000323	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—breast cancer	7.01e-05	0.000323	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—breast cancer	6.99e-05	0.000322	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—breast cancer	6.97e-05	0.000321	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—breast cancer	6.93e-05	0.000319	CcSEcCtD
Triazolam—Anorexia—Epirubicin—breast cancer	6.92e-05	0.000319	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—breast cancer	6.92e-05	0.000318	CcSEcCtD
Triazolam—Oxazepam—CYP3A4—breast cancer	6.9e-05	0.0269	CrCbGaD
Triazolam—Somnolence—Methotrexate—breast cancer	6.9e-05	0.000318	CcSEcCtD
Triazolam—Dizziness—Capecitabine—breast cancer	6.9e-05	0.000317	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—breast cancer	6.86e-05	0.000316	CcSEcCtD
Triazolam—Vomiting—Docetaxel—breast cancer	6.85e-05	0.000315	CcSEcCtD
Triazolam—Temazepam—CYP3A4—breast cancer	6.81e-05	0.0265	CrCbGaD
Triazolam—Dermatitis—Docetaxel—breast cancer	6.78e-05	0.000312	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—breast cancer	6.78e-05	0.000312	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—breast cancer	6.75e-05	0.000311	CcSEcCtD
Triazolam—Headache—Docetaxel—breast cancer	6.75e-05	0.000311	CcSEcCtD
Triazolam—Oedema—Doxorubicin—breast cancer	6.72e-05	0.000309	CcSEcCtD
Triazolam—Fatigue—Methotrexate—breast cancer	6.69e-05	0.000308	CcSEcCtD
Triazolam—Pain—Methotrexate—breast cancer	6.64e-05	0.000305	CcSEcCtD
Triazolam—Vomiting—Capecitabine—breast cancer	6.63e-05	0.000305	CcSEcCtD
Triazolam—Shock—Doxorubicin—breast cancer	6.61e-05	0.000304	CcSEcCtD
Triazolam—Midazolam—CYP3A4—breast cancer	6.61e-05	0.0257	CrCbGaD
Triazolam—Insomnia—Epirubicin—breast cancer	6.57e-05	0.000302	CcSEcCtD
Triazolam—Dermatitis—Capecitabine—breast cancer	6.57e-05	0.000302	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—breast cancer	6.56e-05	0.000302	CcSEcCtD
Triazolam—Headache—Capecitabine—breast cancer	6.53e-05	0.000301	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—breast cancer	6.52e-05	0.0003	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—breast cancer	6.5e-05	0.000299	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—breast cancer	6.48e-05	0.000298	CcSEcCtD
Triazolam—Somnolence—Epirubicin—breast cancer	6.46e-05	0.000297	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—breast cancer	6.41e-05	0.000295	CcSEcCtD
Triazolam—Nausea—Docetaxel—breast cancer	6.4e-05	0.000294	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—breast cancer	6.4e-05	0.000294	CcSEcCtD
Triazolam—Chlorprothixene—ABCB1—breast cancer	6.35e-05	0.0248	CrCbGaD
Triazolam—Gastrointestinal pain—Methotrexate—breast cancer	6.35e-05	0.000292	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—breast cancer	6.32e-05	0.000291	CcSEcCtD
Triazolam—Fatigue—Epirubicin—breast cancer	6.26e-05	0.000288	CcSEcCtD
Triazolam—Pain—Epirubicin—breast cancer	6.21e-05	0.000286	CcSEcCtD
Triazolam—Constipation—Epirubicin—breast cancer	6.21e-05	0.000286	CcSEcCtD
Triazolam—Nausea—Capecitabine—breast cancer	6.19e-05	0.000285	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—breast cancer	6.14e-05	0.000282	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—breast cancer	6.08e-05	0.00028	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—breast cancer	6.04e-05	0.000278	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—breast cancer	5.99e-05	0.000276	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—breast cancer	5.99e-05	0.000275	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—breast cancer	5.98e-05	0.000275	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—breast cancer	5.94e-05	0.000273	CcSEcCtD
Triazolam—Flurazepam—ABCB1—breast cancer	5.93e-05	0.0231	CrCbGaD
Triazolam—Decreased appetite—Doxorubicin—breast cancer	5.84e-05	0.000269	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—breast cancer	5.8e-05	0.000267	CcSEcCtD
Triazolam—Constipation—Doxorubicin—breast cancer	5.75e-05	0.000265	CcSEcCtD
Triazolam—Pain—Doxorubicin—breast cancer	5.75e-05	0.000265	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—breast cancer	5.74e-05	0.000264	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—breast cancer	5.72e-05	0.000263	CcSEcCtD
Triazolam—Diazepam—CYP3A4—breast cancer	5.66e-05	0.0221	CrCbGaD
Triazolam—Asthenia—Methotrexate—breast cancer	5.57e-05	0.000256	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—breast cancer	5.54e-05	0.000255	CcSEcCtD
Triazolam—Midazolam—ABCB1—breast cancer	5.5e-05	0.0214	CrCbGaD
Triazolam—Gastrointestinal pain—Doxorubicin—breast cancer	5.5e-05	0.000253	CcSEcCtD
Triazolam—Pruritus—Methotrexate—breast cancer	5.49e-05	0.000253	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—breast cancer	5.35e-05	0.000246	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—breast cancer	5.31e-05	0.000245	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—breast cancer	5.31e-05	0.000244	CcSEcCtD
Triazolam—Asthenia—Epirubicin—breast cancer	5.21e-05	0.00024	CcSEcCtD
Triazolam—Pruritus—Epirubicin—breast cancer	5.14e-05	0.000237	CcSEcCtD
Triazolam—Dizziness—Methotrexate—breast cancer	5.13e-05	0.000236	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—breast cancer	4.97e-05	0.000229	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—breast cancer	4.95e-05	0.000228	CcSEcCtD
Triazolam—Diazepam—ALB—breast cancer	4.94e-05	0.0192	CrCbGaD
Triazolam—Vomiting—Methotrexate—breast cancer	4.94e-05	0.000227	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—breast cancer	4.89e-05	0.000225	CcSEcCtD
Triazolam—Headache—Methotrexate—breast cancer	4.86e-05	0.000224	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—breast cancer	4.82e-05	0.000222	CcSEcCtD
Triazolam—Dizziness—Epirubicin—breast cancer	4.8e-05	0.000221	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—breast cancer	4.76e-05	0.000219	CcSEcCtD
Triazolam—Diazepam—ABCB1—breast cancer	4.71e-05	0.0184	CrCbGaD
Triazolam—Vomiting—Epirubicin—breast cancer	4.62e-05	0.000213	CcSEcCtD
Triazolam—Nausea—Methotrexate—breast cancer	4.61e-05	0.000212	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—breast cancer	4.6e-05	0.000212	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—breast cancer	4.58e-05	0.000211	CcSEcCtD
Triazolam—Headache—Epirubicin—breast cancer	4.55e-05	0.000209	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—breast cancer	4.44e-05	0.000205	CcSEcCtD
Triazolam—Nausea—Epirubicin—breast cancer	4.32e-05	0.000199	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—breast cancer	4.27e-05	0.000197	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—breast cancer	4.23e-05	0.000195	CcSEcCtD
Triazolam—Headache—Doxorubicin—breast cancer	4.21e-05	0.000194	CcSEcCtD
Triazolam—Nausea—Doxorubicin—breast cancer	3.99e-05	0.000184	CcSEcCtD
Triazolam—CYP2C8—Metabolism—NCOA3—breast cancer	6.75e-06	7.86e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APRT—breast cancer	6.71e-06	7.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A2—breast cancer	6.7e-06	7.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.64e-06	7.73e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA1—breast cancer	6.63e-06	7.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH1—breast cancer	6.63e-06	7.72e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2D6—breast cancer	6.63e-06	7.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CPT1A—breast cancer	6.57e-06	7.65e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCG2—breast cancer	6.57e-06	7.65e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTR—breast cancer	6.57e-06	7.65e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NAT2—breast cancer	6.56e-06	7.64e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—breast cancer	6.55e-06	7.62e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA2—breast cancer	6.51e-06	7.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HPGDS—breast cancer	6.44e-06	7.5e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TYMS—breast cancer	6.43e-06	7.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HBA1—breast cancer	6.4e-06	7.45e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLA2G4A—breast cancer	6.36e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—breast cancer	6.36e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NCOR1—breast cancer	6.36e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.31e-06	7.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ESRRA—breast cancer	6.31e-06	7.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FASN—breast cancer	6.31e-06	7.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCHE—breast cancer	6.28e-06	7.32e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—breast cancer	6.25e-06	7.28e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACHE—breast cancer	6.25e-06	7.28e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A5—breast cancer	6.21e-06	7.23e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—breast cancer	6.09e-06	7.09e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—breast cancer	6.03e-06	7.02e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NQO1—breast cancer	5.99e-06	6.98e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC2A1—breast cancer	5.99e-06	6.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HADHB—breast cancer	5.98e-06	6.97e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPI—breast cancer	5.98e-06	6.97e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ERCC2—breast cancer	5.98e-06	6.96e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.93e-06	6.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP17A1—breast cancer	5.91e-06	6.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS1—breast cancer	5.85e-06	6.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO1—breast cancer	5.85e-06	6.82e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP3A4—breast cancer	5.85e-06	6.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.83e-06	6.79e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.76e-06	6.71e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DPYD—breast cancer	5.75e-06	6.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MED12—breast cancer	5.75e-06	6.7e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1B1—breast cancer	5.75e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2D6—breast cancer	5.74e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.71e-06	6.65e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.71e-06	6.65e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOA—breast cancer	5.66e-06	6.59e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HSP90AA1—breast cancer	5.64e-06	6.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA2—breast cancer	5.64e-06	6.56e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—breast cancer	5.62e-06	6.54e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA3—breast cancer	5.5e-06	6.4e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA1—breast cancer	5.48e-06	6.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UMPS—breast cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADSL—breast cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NME1—breast cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FHL2—breast cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PHGDH—breast cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FASN—breast cancer	5.47e-06	6.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A2—breast cancer	5.46e-06	6.35e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCHE—breast cancer	5.44e-06	6.34e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP19A1—breast cancer	5.4e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—STK11—breast cancer	5.4e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.4e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A5—breast cancer	5.38e-06	6.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BRIP1—breast cancer	5.37e-06	6.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPSE—breast cancer	5.37e-06	6.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDHB—breast cancer	5.37e-06	6.25e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTR—breast cancer	5.35e-06	6.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG2—breast cancer	5.35e-06	6.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CPT1A—breast cancer	5.35e-06	6.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HPGDS—breast cancer	5.24e-06	6.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HBA1—breast cancer	5.21e-06	6.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A1—breast cancer	5.19e-06	6.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NQO1—breast cancer	5.19e-06	6.05e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—breast cancer	5.18e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA3—breast cancer	5.09e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCC1—breast cancer	5.09e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMMR—breast cancer	5.09e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—breast cancer	5.08e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACHE—breast cancer	5.08e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.08e-06	5.92e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP3A4—breast cancer	5.06e-06	5.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.04e-06	5.87e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COMT—breast cancer	5.02e-06	5.85e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—breast cancer	5e-06	5.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1B1—breast cancer	4.98e-06	5.8e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—breast cancer	4.93e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.93e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ITPR1—breast cancer	4.92e-06	5.73e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HSP90AA1—breast cancer	4.88e-06	5.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP17A1—breast cancer	4.81e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO1—breast cancer	4.76e-06	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS1—breast cancer	4.76e-06	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA1—breast cancer	4.75e-06	5.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.75e-06	5.53e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—breast cancer	4.73e-06	5.51e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—breast cancer	4.72e-06	5.5e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.69e-06	5.46e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP19A1—breast cancer	4.68e-06	5.45e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—STK11—breast cancer	4.68e-06	5.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2D6—breast cancer	4.67e-06	5.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA4—breast cancer	4.65e-06	5.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA9—breast cancer	4.65e-06	5.42e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMS—breast cancer	4.65e-06	5.41e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.59e-06	5.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—breast cancer	4.59e-06	5.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOR1—breast cancer	4.59e-06	5.35e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA2—breast cancer	4.59e-06	5.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX2—breast cancer	4.53e-06	5.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA2—breast cancer	4.53e-06	5.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX4—breast cancer	4.48e-06	5.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT1A1—breast cancer	4.48e-06	5.21e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FASN—breast cancer	4.45e-06	5.18e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCHE—breast cancer	4.43e-06	5.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—breast cancer	4.4e-06	5.12e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.39e-06	5.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A5—breast cancer	4.38e-06	5.1e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH1—breast cancer	4.37e-06	5.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA1—breast cancer	4.37e-06	5.09e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—breast cancer	4.36e-06	5.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COMT—breast cancer	4.35e-06	5.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—breast cancer	4.33e-06	5.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NAT2—breast cancer	4.32e-06	5.04e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ERCC2—breast cancer	4.32e-06	5.03e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—breast cancer	4.27e-06	4.97e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ITPR1—breast cancer	4.26e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A1—breast cancer	4.23e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NQO1—breast cancer	4.23e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—breast cancer	4.15e-06	4.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.14e-06	4.82e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP3A4—breast cancer	4.12e-06	4.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.1e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—breast cancer	4.1e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—breast cancer	4.1e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—breast cancer	4.06e-06	4.73e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1B1—breast cancer	4.05e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMS—breast cancer	4.03e-06	4.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—breast cancer	3.98e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.98e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOR1—breast cancer	3.98e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.97e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—breast cancer	3.92e-06	4.56e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA1—breast cancer	3.86e-06	4.5e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—breast cancer	3.81e-06	4.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—STK11—breast cancer	3.81e-06	4.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP19A1—breast cancer	3.81e-06	4.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DPYD—breast cancer	3.79e-06	4.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MED12—breast cancer	3.79e-06	4.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—breast cancer	3.77e-06	4.39e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—breast cancer	3.75e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ERCC2—breast cancer	3.74e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOA—breast cancer	3.73e-06	4.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA3—breast cancer	3.62e-06	4.22e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—breast cancer	3.62e-06	4.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A2—breast cancer	3.6e-06	4.19e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—breast cancer	3.58e-06	4.17e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.58e-06	4.16e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COMT—breast cancer	3.54e-06	4.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CPT1A—breast cancer	3.53e-06	4.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTR—breast cancer	3.53e-06	4.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG2—breast cancer	3.53e-06	4.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—breast cancer	3.52e-06	4.1e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—breast cancer	3.52e-06	4.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—breast cancer	3.48e-06	4.05e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ITPR1—breast cancer	3.47e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPGDS—breast cancer	3.46e-06	4.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HBA1—breast cancer	3.44e-06	4e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—breast cancer	3.41e-06	3.97e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—breast cancer	3.35e-06	3.9e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACHE—breast cancer	3.35e-06	3.9e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—breast cancer	3.34e-06	3.88e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMS—breast cancer	3.28e-06	3.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—breast cancer	3.24e-06	3.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—breast cancer	3.24e-06	3.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.24e-06	3.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOR1—breast cancer	3.24e-06	3.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP17A1—breast cancer	3.17e-06	3.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO1—breast cancer	3.14e-06	3.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS1—breast cancer	3.14e-06	3.66e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—breast cancer	3.12e-06	3.64e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—breast cancer	3.1e-06	3.61e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.1e-06	3.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2D6—breast cancer	3.08e-06	3.59e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—breast cancer	3.07e-06	3.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ERCC2—breast cancer	3.05e-06	3.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA2—breast cancer	3.02e-06	3.52e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—breast cancer	3e-06	3.49e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—breast cancer	2.96e-06	3.45e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—breast cancer	2.95e-06	3.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FASN—breast cancer	2.93e-06	3.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCHE—breast cancer	2.92e-06	3.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A5—breast cancer	2.89e-06	3.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—breast cancer	2.86e-06	3.33e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—breast cancer	2.83e-06	3.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NQO1—breast cancer	2.79e-06	3.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A1—breast cancer	2.79e-06	3.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1B1—breast cancer	2.67e-06	3.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—breast cancer	2.64e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.62e-06	3.05e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—breast cancer	2.61e-06	3.04e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—breast cancer	2.6e-06	3.02e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—breast cancer	2.59e-06	3.02e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—breast cancer	2.56e-06	2.99e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA1—breast cancer	2.55e-06	2.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.52e-06	2.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—STK11—breast cancer	2.51e-06	2.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP19A1—breast cancer	2.51e-06	2.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—breast cancer	2.45e-06	2.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—breast cancer	2.4e-06	2.8e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COMT—breast cancer	2.34e-06	2.72e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—breast cancer	2.32e-06	2.71e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—breast cancer	2.29e-06	2.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ITPR1—breast cancer	2.29e-06	2.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—breast cancer	2.26e-06	2.64e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—breast cancer	2.26e-06	2.63e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—breast cancer	2.24e-06	2.61e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—breast cancer	2.2e-06	2.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—breast cancer	2.2e-06	2.56e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMS—breast cancer	2.16e-06	2.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.14e-06	2.49e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOR1—breast cancer	2.14e-06	2.49e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—breast cancer	2.14e-06	2.49e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—breast cancer	2.11e-06	2.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—breast cancer	2.09e-06	2.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—breast cancer	2.05e-06	2.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—breast cancer	2.02e-06	2.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ERCC2—breast cancer	2.01e-06	2.34e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—breast cancer	2e-06	2.32e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—breast cancer	1.96e-06	2.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—breast cancer	1.89e-06	2.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—breast cancer	1.84e-06	2.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—breast cancer	1.83e-06	2.13e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—breast cancer	1.8e-06	2.1e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—breast cancer	1.74e-06	2.03e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—breast cancer	1.59e-06	1.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—breast cancer	1.59e-06	1.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—breast cancer	1.59e-06	1.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—breast cancer	1.39e-06	1.62e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—breast cancer	1.38e-06	1.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—breast cancer	1.38e-06	1.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—breast cancer	1.32e-06	1.53e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—breast cancer	1.3e-06	1.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—breast cancer	1.22e-06	1.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—breast cancer	1.2e-06	1.4e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—breast cancer	1.13e-06	1.31e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—breast cancer	1.12e-06	1.31e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—breast cancer	1.05e-06	1.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—breast cancer	9.18e-07	1.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—breast cancer	7.41e-07	8.63e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—breast cancer	6.05e-07	7.05e-06	CbGpPWpGaD
